Ocuphire Pharma Inc.

01/20/2021 | Press release | Distributed by Public on 01/20/2021 06:01

Ocuphire Announces Publication of ORION-1 Phase 2 Results for Nyxol in Clinical Ophthalmology and Presentation at the January OIS Presbyopia Innovation Showcase